Validation of the Villalta scale in assessing post-thrombotic syndrome using clinical, duplex, and hemodynamic comparators.

J Vasc Surg Venous Lymphat Disord

Josef Pflug Vascular Laboratory, Ealing Hospital, Middlesex, United Kingdom; Department of Vascular Surgery, Imperial College, London, United Kingdom; Department of Vascular Surgery, Northwick Park Hospital, Middlesex, United Kingdom.

Published: January 2014

Introduction: The Villalta scale (VS) was developed by Prandoni and introduced as an abstract in 1994 as a disease-specific assessment questionnaire to diagnose and classify the severity of post-thrombotic syndrome (PTS). While validation using quality-of-life assessments and reproducibility have been reported as good, limited data exist as how the VS compares against generalized assessment tests in defining the severity of PTS. The aim of this study was to compare the VS against the Venous Clinical Severity Score (VCSS), the C of the CEAP classification, the Venous Segmental Disease Score (VSDS), and the Venous Filling Index (VFI) of air plethysmography.

Methods: Baseline data generated from a recent single-center prospective clinical trial comparing graduated elastic compression stocking performance on 40 legs in 34 patients with PTS were analyzed. Ancillary data from this study were used to assess the measurement properties of the VS. All the legs had PTS defined as persisting leg symptoms/signs at least 6 months after a deep vein thrombosis with evidence of deep venous obstruction and/or deep venous reflux on duplex ultrasound. Unadjusted VS scores were used so patients with ulceration with a VS <15 were not automatically upgraded to a score of 15.

Results: The number of legs by the C part of the CEAP classification was: C0 = 2, C2 = 1, C3 = 3, C4a = 12, C4b = 7, C5 = 12, and C6 = 3. The median (interquartile range) of age, VS, VCSS, VSDS, and VFI were 62 years (52-73 years), 10 (5-14), 8 (5-10), 5 (4-6.5), and 4.9 (2.8-7.9) mL/s, respectively. The VS had a highly significant and moderate-to-good correlation (Spearman) with the VCSS (r = .609; P < .0005) and the C of CEAP (r = .556, P < .0005). When the VFI was used as a hemodynamic benchmark, the VS correlation outperformed the other assessment tests (r = .499; P = .001). However, the VCSS correlation with the VFI was also significant (r = .480; P = .002). Surprisingly, the VSDS did not correlate with any assessment tests. No correlation could be detected within the VS between patient symptoms and their clinical signs. Correlations between the VS and the VCSS (r = .775) and C class (r = .779) improved when the VS patient-reported part was excluded.

Conclusions: These results indicate that the VCSS and the C of CEAP may also be useful in the assessment of PTS severity, and the VFI may provide a clinically meaningful hemodynamic evaluation. However, using the VFI as a reference, there was no essential difference between the VS and the VCSS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvsv.2013.06.003DOI Listing

Publication Analysis

Top Keywords

villalta scale
8
post-thrombotic syndrome
8
deep venous
8
venous
5
validation villalta
4
scale assessing
4
assessing post-thrombotic
4
syndrome clinical
4
clinical duplex
4
duplex hemodynamic
4

Similar Publications

One-stop endovenous laser ablation leads to superior outcomes for varicose veins and iliac vein compression.

Sci Rep

January 2025

Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210009, China.

To retrospectivly investigate the short-term clinical outcomes of one-stop and two-staged endovenous laser ablation (EVLA) procedures for treatment of varicose veins (VVs) and iliac vein compression syndrome (IVCS). In this study, 424 patients were treated for VVs and IVCS from June 2017 to June 2020, 91 underwent one-stop stent angioplasty (SA) and EVLA, 132 underwent two-staged SA and EVLA, 104 underwent one-stop balloon angioplasty (BA) and EVLA, and 97 underwent two-staged BA and EVLA. Clinical outcomes and complications were recorded at 3 and 12 months post-intervention.

View Article and Find Full Text PDF

Freshwater environments are biodiversity hotspots under multiple pressures, including pesticide exposure. S-metolachlor, a widely used herbicide, can induce genotoxic, cytotoxic and physiological effects in captive fish, but we have a limited understanding of the effects of exposure to S-metolachlor in free-living vertebrates. We carried out an original field experiment using integrative approaches across biological levels and temporal scales.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined how the Villalta Scale (VS) for diagnosing postthrombotic syndrome (PTS) varied between self-reported Black and White patients in a trial focused on improving outcomes after deep vein thrombosis (DVT).
  • - Results showed that while overall VS scores were similar between the two racial groups, Black participants had a significantly lower score for one specific sign (venous ectasia), indicating potential differences in symptom reporting or clinician evaluation.
  • - The study highlights potential racial disparities in the assessment of PTS symptoms and suggests the need for further investigation into how race may influence clinician ratings and patient experiences.
View Article and Find Full Text PDF

Recent research suggests that a polygeneric immunogen made from the venoms of the most medically important viperid and elapid snakes in sub-Saharan Africa could elicit a broader antibody response in horses compared to the current EchiTAb-plus-ICP antivenom, especially against neurotoxic elapid venoms. To test this, 25 horses that have been regularly immunized to produce this antivenom were reimmunized with an immunogen containing 22 venoms from various snake species from the genera , , , and both spitting and non-spitting . The plasma collected from these horses was processed using the caprylic acid method to produce an industrial-scale freeze-dried antivenom.

View Article and Find Full Text PDF

Objective: Patients with mixed-type lower extremity deep vein thrombosis (DVT) have a higher incidence of post-thrombotic syndrome (PTS) after endovascular treatment (EVT). This study aimed to identify risk factors associated with PTS in these patients after EVT.

Methods: This retrospective study included patients diagnosed with acute mixed-type lower extremity DVT who underwent EVT between January 2020 and December 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!